winetrooper posted:For any biotech people, SGEN and NKTR are ripe for long term holds. I know a guy who works in that space and he feels strongly that SGEN and NKTR are takeout ripened and could be doubles this year or next. Both have impressive products in circulation and some income along with good pipelines.
I hope you got out of NKTR after it has that nice run.
It got smashed by over 40% today.
I guess these latest results call in to question their platform.